CAS: 922139-31-9 - Recilisib sodium
Fórmula:C16H13ClO4S·Na
InChI:InChI=1S/C16H13ClO4S.Na/c17-15-7-3-13(4-8-15)11-22(20,21)10-9-12-1-5-14(6-2-12)16(18)19;/h1-10H,11H2,(H,18,19);/b10-9+;
Clave InChI:InChIKey=NNNJPDWCCZUPQL-RRABGKBLSA-N
SMILES:[Na].O=C(O)C1=CC=C(C=C1)C=CS(=O)(=O)CC2=CC=C(Cl)C=C2
- Sinónimos:
- Ex-Rad
- Recilisib sodium
- ON 01210.Na
- Benzoic acid, 4-[(1E)-2-[[(4-chlorophenyl)methyl]sulfonyl]ethenyl]-, sodium salt (1:1)
- Sodium 4-[(1E)-2-[[(4-chlorophenyl)methyl]sulfonyl]ethenyl]benzoate (1:1)
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Recilisib sodium REF: TM-T13862LCAS: 922139-31-9 | - - - | 1.418,00 €~2.331,00 € | Lun 23 Dic 24 | |
Recilisib sodium REF: 3D-XLB13931CAS: 922139-31-9 | Min. 95% | A consultar | Lun 27 Ene 25 |
Recilisib sodium
CAS:922139-31-9
Recilisib (ON 01210.Na) is a radioprotective agent altering cancer cell cycles and preventing radiation-induced apoptosis.
Fórmula:
C16H13ClNaO4S
Forma y color:
Solid
Peso molecular:
359.78
Ref: TM-T13862L
25mg | 1.418,00 € | ||
50mg | 1.846,00 € | ||
100mg | 2.331,00 € |
Entrega estimada en Estados Unidos, el Lunes 23 de Diciembre de 2024
Recilisib sodium
CAS:922139-31-9
Recilisib sodium is an experimental drug that is being studied for its potential use in …
Fórmula:
C16H12ClNaO4S
Pureza:
Min. 95%
Peso molecular:
358.8 g/mol
Ref: 3D-XLB13931
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 27 de Enero de 2025